| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 0 | 0 | 0 | 0 | 18.080 | 44.177 | 23.940 | 19.201 |
| Total Income - EUR | - | 0 | 0 | 0 | 0 | 61 | 18.080 | 44.232 | 23.940 | 24.318 |
| Total Expenses - EUR | - | 0 | 0 | 0 | 1.171 | 5.138 | 9.810 | 16.410 | 30.175 | 35.731 |
| Gross Profit/Loss - EUR | - | 0 | 0 | 0 | -1.171 | -5.077 | 8.270 | 27.822 | -6.235 | -11.413 |
| Net Profit/Loss - EUR | - | 0 | 0 | 0 | -1.171 | -5.077 | 7.728 | 26.793 | -6.438 | -11.481 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Neuromedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 8.058 | 11.495 | 10.920 | 10.409 | 2.169 |
| Current Assets | - | 0 | 0 | 0 | 5.028 | 271 | 1.669 | 9.540 | 27.373 | 13.992 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 0 | 0 | 8.666 | 20.050 | 4.503 |
| Cash | - | 0 | 0 | 0 | 5.028 | 271 | 1.669 | 875 | 7.322 | 9.489 |
| Shareholders Funds | - | -4.191 | -4.121 | -4.045 | -5.138 | -10.118 | -2.165 | 24.621 | 18.108 | -15.162 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 4.191 | 4.121 | 4.045 | 14.377 | 85.166 | 97.724 | 78.490 | 88.340 | 85.948 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Neuromedica Srl